Loading organizations...
§ Private Profile · Waltham, MA, USA
Pharmaceuticals for diseases caused by oxidative stress and tissue damage.
Transcend Therapeutics has raised $40.0M across 1 funding round.
Transcend Therapeutics has raised $40.0M in total across 1 funding round.
Transcend Therapeutics has raised $40.0M across 1 funding round. Most recently, it raised $40.0M Series A in February 2023.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Feb 23, 2023 | $40M Series A | Falcon Edge Capital, Integrated | Kevin Ryan, Emerald Investment Managers, Global Founders Capital | Announced |
Transcend Therapeutics has raised $40.0M in total across 1 funding round.
Transcend Therapeutics's investors include Falcon Edge Capital, Integrated, Kevin Ryan, Emerald Investment Managers, Global Founders Capital.